UTI

UTI completes 2.5 billion won 7th CB issuance, potential dilution around 4%


  • UTI has completed the issuance of 2.5 billion won in 7th unsecured private convertible bonds. The payment date is July 15, 2026, and the bonds are not planned for listing.
  • This convertible bond issuance may result in a potential dilution of approximately 4%, which could affect existing shareholder value.
  • The purpose of the fundraising was not disclosed, but the issuance was conducted privately.
  • [AI Summary]UTI completed the issuance of 2.5 billion won in 7th CB, leading to potential dilution of about 4%. As a private placement with undisclosed purpose, the impact on shareholder value is neutral.

KOSDAQ Filing Information


  • Result of Securities Issuance (Voluntary Disclosure) (7th Series CB)
  • Company: UTI (179900)
  • Submission: UTI INC.
  • Under KRX KOSDAQ Market Division

  • Shares: 19,790,412
  • Price: 3,130 KRW
  • Market Cap: 61.9 B KRW